BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

260 related articles for article (PubMed ID: 33351131)

  • 21. Mutations in the CCND1 and CCND2 genes are frequent events in adult patients with t(8;21)(q22;q22) acute myeloid leukemia.
    Eisfeld AK; Kohlschmidt J; Schwind S; Nicolet D; Blachly JS; Orwick S; Shah C; Bainazar M; Kroll KW; Walker CJ; Carroll AJ; Powell BL; Stone RM; Kolitz JE; Baer MR; de la Chapelle A; Mrózek K; Byrd JC; Bloomfield CD
    Leukemia; 2017 Jun; 31(6):1278-1285. PubMed ID: 27843138
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Core binding factor acute myeloid leukemia.
    Paschka P
    Semin Oncol; 2008 Aug; 35(4):410-7. PubMed ID: 18692691
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Modeling interactions between leukemia-specific chromosomal changes, somatic mutations, and gene expression patterns during progression of core-binding factor leukemias.
    Jones D; Yao H; Romans A; Dando C; Pierce S; Borthakur G; Hamilton A; Bueso-Ramos C; Ravandi F; Garcia-Manero G; Kantarjian H
    Genes Chromosomes Cancer; 2010 Feb; 49(2):182-91. PubMed ID: 19908318
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Incidence and prognostic impact of c-Kit, FLT3, and Ras gene mutations in core binding factor acute myeloid leukemia (CBF-AML).
    Boissel N; Leroy H; Brethon B; Philippe N; de Botton S; Auvrignon A; Raffoux E; Leblanc T; Thomas X; Hermine O; Quesnel B; Baruchel A; Leverger G; Dombret H; Preudhomme C; ;
    Leukemia; 2006 Jun; 20(6):965-70. PubMed ID: 16598313
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [The impact of KIT and other concomitant gene mutations on the prognoses of patients with core-binding factor acute myeloid leukemia].
    Wang F; Wang W; Liu M; Zhang Y; Chen X; Yuan LL; Ma XL; Nie DJ; Wang MY; Zhang Y; Zhang W; Liu MY; Liu HX
    Zhonghua Yi Xue Za Zhi; 2020 Jan; 100(3):225-229. PubMed ID: 32008291
    [No Abstract]   [Full Text] [Related]  

  • 26. Heterogeneity in CBF beta/MYH11 fusion messages encoded by the inv(16)(p13q22) and the t(16;16)(p13;q22) in acute myelogenous leukemia.
    Shurtleff SA; Meyers S; Hiebert SW; Raimondi SC; Head DR; Willman CL; Wolman S; Slovak ML; Carroll AJ; Behm F
    Blood; 1995 Jun; 85(12):3695-703. PubMed ID: 7780153
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Comparison of therapy-related and de novo core binding factor acute myeloid leukemia: A bone marrow pathology group study.
    Rogers HJ; Wang X; Xie Y; Davis AR; Thakral B; Wang SA; Borthakur G; Cantu MD; Margolskee EM; Philip JKS; Sukhanova M; Bagg A; Bueso-Ramos CE; Orazi A; Arber DA; Hsi ED; Hasserjian RP
    Am J Hematol; 2020 Jul; 95(7):799-808. PubMed ID: 32249963
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cooperating mutations of receptor tyrosine kinases and Ras genes in childhood core-binding factor acute myeloid leukemia and a comparative analysis on paired diagnosis and relapse samples.
    Shih LY; Liang DC; Huang CF; Chang YT; Lai CL; Lin TH; Yang CP; Hung IJ; Liu HC; Jaing TH; Wang LY; Yeh TC
    Leukemia; 2008 Feb; 22(2):303-7. PubMed ID: 17960171
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The Prognostic Significance of c-KIT Mutations in Core Binding Factor Acute Myeloid Leukemia.
    Shafik NF; Ibraheem D; Selim MM; Allam RM; Fathalla LA
    Clin Lymphoma Myeloma Leuk; 2022 Jun; 22(6):e363-e375. PubMed ID: 34972661
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prognostic Importance of C-KIT Mutations in Core Binding Factor Acute Myeloid Leukemia: A Systematic Review.
    Ayatollahi H; Shajiei A; Sadeghian MH; Sheikhi M; Yazdandoust E; Ghazanfarpour M; Shams SF; Shakeri S
    Hematol Oncol Stem Cell Ther; 2017 Mar; 10(1):1-7. PubMed ID: 27613372
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Core-binding factor acute myeloid leukemia.
    Sangle NA; Perkins SL
    Arch Pathol Lab Med; 2011 Nov; 135(11):1504-9. PubMed ID: 22032582
    [TBL] [Abstract][Full Text] [Related]  

  • 32. KIT mutations correlate with adverse survival in children with core-binding factor acute myeloid leukemia.
    Chen X; Dou H; Wang X; Huang Y; Lu L; Bin J; Su Y; Zou L; Yu J; Bao L
    Leuk Lymphoma; 2018 Apr; 59(4):829-836. PubMed ID: 28792268
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Molecular and clinical advances in core binding factor primary acute myeloid leukemia: a paradigm for translational research in malignant hematology.
    Marcucci G; Caligiuri MA; Bloomfield CD
    Cancer Invest; 2000; 18(8):768-80. PubMed ID: 11107447
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prognostic Significance of KIT Mutations in Core-Binding Factor Acute Myeloid Leukemia: A Systematic Review and Meta-Analysis.
    Chen W; Xie H; Wang H; Chen L; Sun Y; Chen Z; Li Q
    PLoS One; 2016; 11(1):e0146614. PubMed ID: 26771376
    [TBL] [Abstract][Full Text] [Related]  

  • 35. D816 mutation of the KIT gene in core binding factor acute myeloid leukemia is associated with poorer prognosis than other KIT gene mutations.
    Yui S; Kurosawa S; Yamaguchi H; Kanamori H; Ueki T; Uoshima N; Mizuno I; Shono K; Usuki K; Chiba S; Nakamura Y; Yanada M; Kanda J; Tajika K; Gomi S; Fukunaga K; Wakita S; Ryotokuji T; Fukuda T; Inokuchi K
    Ann Hematol; 2017 Oct; 96(10):1641-1652. PubMed ID: 28762080
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prognostic of Core Binding Factor (CBF) Acute Myeloid Leukemia With Complex Karyotype.
    Marcault C; Boissel N; Haferlach C; Loschi M; Raynaud S; Cluzeau T
    Clin Lymphoma Myeloma Leuk; 2022 Mar; 22(3):e199-e205. PubMed ID: 34674982
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The clinical mutatome of core binding factor leukemia.
    Opatz S; Bamopoulos SA; Metzeler KH; Herold T; Ksienzyk B; Bräundl K; Tschuri S; Vosberg S; Konstandin NP; Wang C; Hartmann L; Graf A; Krebs S; Blum H; Schneider S; Thiede C; Middeke JM; Stölzel F; Röllig C; Schetelig J; Ehninger G; Krämer A; Braess J; Görlich D; Sauerland MC; Berdel WE; Wörmann BJ; Hiddemann W; Spiekermann K; Bohlander SK; Greif PA
    Leukemia; 2020 Jun; 34(6):1553-1562. PubMed ID: 31896782
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Additional chromosomal abnormalities in core-binding factor acute myeloid leukemia.
    Hsiao HH; Liu YC; Wang HC; Tsai YF; Wu CH; Cho SF; Hsu JF; Huang CT; Hsiao SY; Lee CP; Chang CS; Lin SF; Liu TC
    Genet Mol Res; 2015 Dec; 14(4):17028-33. PubMed ID: 26681050
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Core binding factor acute myeloid leukemia (CBF-AML): is high-dose Ara-C (HDAC) consolidation as effective as you think?
    Dombret H; Preudhomme C; Boissel N
    Curr Opin Hematol; 2009 Mar; 16(2):92-7. PubMed ID: 19468270
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Monitoring of clonal evolution of double C-KIT exon 17 mutations by Droplet Digital PCR in patients with core-binding factor acute myeloid leukemia.
    Tan Y; Liu Z; Wang W; Zhu G; Guo J; Chen X; Zheng C; Xu Z; Chang J; Ren F; Wang H
    Leuk Res; 2018 Jun; 69():89-93. PubMed ID: 29705537
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.